Your browser doesn't support javascript.
loading
Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis.
Kawanaka, Miwa; Nishino, Ken; Kawada, Mayuko; Ishii, Katsunori; Tanikawa, Tomohiro; Katsumata, Ryo; Urata, Noriyo; Nakamura, Jun; Suehiro, Mitsuhiko; Haruma, Ken; Kawamoto, Hirofumi.
Afiliación
  • Kawanaka M; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan. m.kawanaka@med.kawasaki-m.ac.jp.
  • Nishino K; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
  • Kawada M; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
  • Ishii K; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
  • Tanikawa T; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
  • Katsumata R; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
  • Urata N; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
  • Nakamura J; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
  • Suehiro M; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
  • Haruma K; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
  • Kawamoto H; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
BMC Gastroenterol ; 23(1): 143, 2023 May 10.
Article en En | MEDLINE | ID: mdl-37165352
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. The serum level of soluble CD163 (sCD163), a macrophage activation marker, is associated with liver tissue changes; however, its prognostic value is unknown. Here, we determined the utility of sCD163 as a marker for hepatocellular carcinoma (HCC) and prognostic marker for NAFLD. METHODS: This retrospective study obtained data regarding serum sCD163 levels, liver histology, and background factors associated with NAFLD in 287 patients (men/women, 140/147; average age, 53 ± 14 years) with NAFLD who underwent liver biopsy. Repeated liver biopsies of 287 patients with NAFLD (5.0 ± 2.7 years) were compared regarding serum sCD163 levels and liver tissue changes (stage, grade, steatosis, and NAFLD activity score). RESULTS: Serum sCD163 levels increased with the progression of liver fibrosis and inflammation (both P < 0.05) and were particularly helpful in distinguishing cases of Grade 4 fibrosis (P < 0.001). Levels of sCD163 significantly decreased in patients with NAFLD exhibiting alleviated fibrosis and inflammation (P < 0.05). We could also predict the development of HCC and associated mortality based on serum sCD163 levels at the time of NAFLD diagnosis. Serum sCD163 levels were higher in patients with HCC than in patients without HCC (1074 ± 379 ng/ml vs. 669 ± 261 ng/ml; P < 0.0001), and the same trend was observed for mortality. CONCLUSIONS: The serum sCD163 level reflects the progression of fibrosis and inflammation in liver tissues, showing much promise as a noninvasive biomarker for nonalcoholic steatohepatitis and NAFLD as well as a possible predictor of HCC development and patient prognosis.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Enfermedad del Hígado Graso no Alcohólico / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Enfermedad del Hígado Graso no Alcohólico / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido